Cargando…

Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment

In the last years, the treatment of multiple sclerosis (MS) patients with natalizumab has been associated with the occurrence of progressive multifocal leukoencephalopathy (PML) caused by human polyomavirus JC (JCV). Here, we have shown a significant correlation between patients with JC viruria and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pietropaolo, Valeria, Bellizzi, Anna, Anzivino, Elena, Iannetta, Marco, Zingaropoli, Maria Antonella, Rodio, Donatella Maria, Morreale, Manuela, Pontecorvo, Simona, Francia, Ada, Vullo, Vincenzo, Palamara, Anna Teresa, Ciardi, Maria Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628051/ https://www.ncbi.nlm.nih.gov/pubmed/25930159 http://dx.doi.org/10.1007/s13365-015-0338-y

Ejemplares similares

JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus
por: Zingaropoli, Maria A., et al.
Publicado: (2018)

New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy
por: Bellizzi, Anna, et al.
Publicado: (2013)

Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation
por: Iannetta, Marco, et al.
Publicado: (2016)

Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study
por: Bellizzi, Anna, et al.
Publicado: (2013)

Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection
por: Prezioso, Carla, et al.
Publicado: (2017)

Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study
por: Rodio, Donatella Maria, et al.
Publicado: (2016)

Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients
por: Iannetta, Marco, et al.
Publicado: (2019)

Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment
por: Prezioso, Carla, et al.
Publicado: (2022)

The DNA damage response promotes polyomavirus JC infection by nucleus to cytoplasm NF- kappaB activation
por: White, Martyn K., et al.
Publicado: (2017)

HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity
por: Iannetta, Marco, et al.
Publicado: (2013)

Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences
por: Umbro, Ilaria, et al.
Publicado: (2013)

Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus
por: Werner, Milton H., et al.
Publicado: (2016)

CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection
por: Wollebo, Hassen S., et al.
Publicado: (2015)

Epigenetic regulation of polyomavirus JC
por: Wollebo, Hassen S, et al.
Publicado: (2013)

Polyomaviruses shedding in stool of patients with hematological disorders: detection analysis and study of the non-coding control region’s genetic variability
por: Prezioso, Carla, et al.
Publicado: (2019)

The oncogenic roles of JC polyomavirus in cancer
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis
por: Ciardi, Maria Rosa, et al.
Publicado: (2020)

Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab
por: Anzivino, Elena, et al.
Publicado: (2011)

JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
por: Mancuso, Roberta, et al.
Publicado: (2012)

Biogenesis of JC polyomavirus associated extracellular vesicles
por: Morris-Love, Jenna, et al.
Publicado: (2022)

Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
por: Perkins, Molly R., et al.
Publicado: (2012)

Merkel Cell Polyomavirus (MCPyV) in the Context of Immunosuppression: Genetic Analysis of Noncoding Control Region (NCCR) Variability among a HIV-1-Positive Population
por: Prezioso, Carla, et al.
Publicado: (2020)

Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy
por: Clausi, Valeria, et al.
Publicado: (2015)

Association between the JC Polyomavirus Infection and Male Infertility
por: Comar, Manola, et al.
Publicado: (2012)

Rad51 Activates Polyomavirus JC Early Transcription
por: White, Martyn K., et al.
Publicado: (2014)

Review on the role of the human Polyomavirus JC in the development of tumors
por: Delbue, Serena, et al.
Publicado: (2017)

Prevalence of Human Polyomavirus JC and BK in Normal Population
por: Karimi Dehcheshmeh, Lila, et al.
Publicado: (2020)

Outcomes of Living Kidney Donor Candidates and Living Kidney Recipient Candidates with JC Polyomavirus and BK Polyomavirus Viruria
por: Querido, Sara, et al.
Publicado: (2021)

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis
por: Ciardi, Maria R, et al.
Publicado: (2018)

Merkel Cell Polyomavirus DNA Detection in Respiratory Samples: Study of a Cohort of Patients Affected by Cystic Fibrosis
por: Prezioso, Carla, et al.
Publicado: (2019)

JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
por: Diotti, Roberta Antonia, et al.
Publicado: (2013)

JC Polyomavirus Uses Extracellular Vesicles To Infect Target Cells
por: Morris-Love, Jenna, et al.
Publicado: (2019)

Complexities of JC Polyomavirus Receptor-Dependent and -Independent Mechanisms of Infection
por: Morris-Love, Jenna, et al.
Publicado: (2022)

306. Determining natural killer cell responses to JC polyomavirus
por: Tan, C Sabrina, et al.
Publicado: (2023)

Genome Sequence of a Central Chimpanzee-Associated Polyomavirus Related to BK and JC Polyomaviruses, Pan troglodytes troglodytes Polyomavirus 1
por: Madinda, Nadège F., et al.
Publicado: (2015)

A globally applicable PCR-based detection and discrimination of BK and JC polyomaviruses
por: de Souza, Leandro Magalhães, et al.
Publicado: (2018)

Sequencing and Analysis of JC Virus DNA From Natalizumab-Treated PML Patients
por: Reid, Carl E., et al.
Publicado: (2011)

Viral miRNAs in plasma and urine divulge JC polyomavirus infection
por: Lagatie, Ole, et al.
Publicado: (2014)

Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions
por: Atkinson, Abigail L., et al.
Publicado: (2020)

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
por: van Lierop, ZYGJ, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_or3skoaddftu0u361m5vqhsk5c